HAYA Therapeutics
SwitzerlandEntry
2021
Hold
5yr
Status
Active
Who owns HAYA Therapeutics?
HAYA Therapeutics is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund II (2021 vintage), since 2021. Across its history, HAYA Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Apollo Health VenturesApollo Health Ventures Fund II · 2021 · Life Sciences VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2021 · present
Apollo Health VenturesActive
2021 · present(5yr) · Apollo Health Ventures Fund II · 2021 · Life Sciences VC
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Capital X · 2021 · Life Sciences VC
More from Apollo Health Ventures Fund II
Other portfolio companies in the same fund.
US
Germany
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Haya Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Haya Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue